Jack Nielsen, Director at Harmony Biosciences Holdings, Inc. (HRMY), sold 221,502 shares at $60.35 ($13.3M) on 2022-12-07, disclosed to the SEC on 2022-12-09.
Open-market sale of $13.3M HRMY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.35 | 64,026 | $3.9M | 29.0% |
| 2 | $60.35 | 64,026 | $3.9M | 29.0% |
| 3 | $59.90 | 36,878 | $2.2M | 16.6% |
| 4 | $59.90 | 36,878 | $2.2M | 16.6% |
| 5 | $59.89 | 9,847 | $590K | 4.4% |
| 6 | $59.89 | 9,847 |
| $590K |
| 4.4% |
| Total | $60.16 avg | 221,502 | $13.3M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-22 | $7.7M | — | Filing → |
| HRMY | SELL | 2022-11-15 | $16.1M | — | Filing → |
| HRMY | SELL | 2022-08-08 | $13.2M | — | Filing → |